Lv41
402 积分 2026-07-26 加入
Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma
57分钟前
已完结
Hepatic arterial infusion of GEMOX plus systemic gemcitabine chemotherapy combined with lenvatinib and PD-1 inhibitor in large unresectable intrahepatic cholangiocarcinoma
1小时前
已完结
Histopathologic Grading of Residual Tumor Predicts Survival of Intrahepatic Cholangiocarcinoma Patients Treated With Neoadjuvant Therapy
1小时前
已完结
Case of an Inflammatory Myofibroblastic Tumor of the Duodenum
4天前
已关闭
Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma
13天前
已完结
EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
29天前
已完结
Targeting MUC16 suppresses malignant progression and chemoresistance in large-duct type intrahepatic cholangiocarcinoma
29天前
已完结
Survival Outcomes of Microwave Ablation Compared with Repeat Liver Resection in the Treatment of Recurrent Intrahepatic Cholangiocarcinoma
1个月前
已完结
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
1个月前
已完结
皖公网安备34019202002308
